Armistice Capital’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Armistice Capital’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,324,000	Closed	-$62M	–	216
2022 Q1	$62M	Buy	3,324,000 +2,228,000	+203%	+$40.1M	1.2%	22
2021 Q4	$23.4M	Sell	1,096,000 -1,204,000	-52%	-$23.7M	0.38%	55
2021 Q3	$42.5M	Buy	2,300,000 +628,000	+38%	+$12.6M	0.72%	34
2021 Q2	$35.8M	Sell	1,672,000 -524,000	-24%	-$10.7M	0.64%	45
2021 Q1	$42.4M	Buy	+2,196,000	New	+$38.7M	0.97%	34

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Armistice Capital's OCDX Position: Q2 2022 in Review

Armistice Capital sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 3,324,000 shares — an estimated $62M sold.

Armistice Capital first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $62M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Armistice Capital reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Armistice Capital sold 3,324,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $62M.
Armistice Capital first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Armistice Capital's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $62M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Armistice Capital's 13F filing for Q2 2022, filed 15 Aug 2022.